Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gyre Therapeutics (GYRE) Gross Profit: 2009-2024

Historic Gross Profit for Gyre Therapeutics (GYRE) over the last 16 years, with Dec 2024 value amounting to $101.9 million.

  • Gyre Therapeutics' Gross Profit rose 17.96% to $28.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $102.4 million, marking a year-over-year increase of 1.32%. This contributed to the annual value of $101.9 million for FY2024, which is 6.38% down from last year.
  • Latest data reveals that Gyre Therapeutics reported Gross Profit of $101.9 million as of FY2024, which was down 6.38% from $108.8 million recorded in FY2023.
  • Over the past 5 years, Gyre Therapeutics' Gross Profit peaked at $108.8 million during FY2023, and registered a low of -$42,000 during FY2021.
  • Moreover, its 3-year median value for Gross Profit was $101.9 million (2024), whereas its average is $86.2 million.
  • Its Gross Profit has fluctuated over the past 5 years, first soared by 212,771.43% in 2020, then tumbled by 100.28% in 2021.
  • Gyre Therapeutics' Gross Profit (Yearly) stood at $14.9 million in 2020, then slumped by 100.28% to -$42,000 in 2021, then skyrocketed by 114,509.52% to $48.1 million in 2022, then surged by 126.45% to $108.8 million in 2023, then fell by 6.38% to $101.9 million in 2024.